Alnylam (ALNY), Genzyme (SNY) Enter RNAi Development for ATTR Solution in Asia
Go back to Alnylam (ALNY), Genzyme (SNY) Enter RNAi Development for ATTR Solution in Asia| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 236.22 +6.92 (3.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $229.30 | 52 Week High | $109.10 | |||
| Open | $228.88 | 52 Week Low | $31.38 | |||
| Day High | $238.97 | P/E | N/A | |||
| Day Low | $228.34 | EPS | $-1.45 | |||
| Volume | 1,906,391 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 45.85 +0.70 (1.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.15 | 52 Week High | $44.76 | |||
| Open | $45.26 | 52 Week Low | $36.81 | |||
| Day High | $46.11 | P/E | N/A | |||
| Day Low | $45.25 | EPS | $0.00 | |||
| Volume | 1,860,731 | |||||
